Russia Orthobiologics Market Outlook to 2020

News provided by

May 27, 2014, 09:29 ET

LONDON, May 27, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:

Russia Orthobiologics Market Outlook to 2020

http://www.reportbuyer.com/pharma_healthcare/treatments/orthopaedic/russia_orthobiologics_market_outlook_2020.html

Summary

GlobalData's new report, "Russia Orthobiologics Market Outlook to 2020", provides key market data on the Russia Orthobiologics market. The report provides value, in millions of US dollars, and volume (in units) and average price data (in US dollars), within market categories - Bone Graft Substitutes, Viscosupplementation, Bone Allografts and Bone Growth Stimulators.

The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Orthobiologics market wherever available.

The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible.

The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers.

Capital equipment-based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Data for average number of units per facility is used to arrive at the installed base of the capital equipment. Sales for a particular year are arrived at by calculating the replacement units and new units (additional and first-time purchases).

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

- Market size for Orthobiologics market categories - Bone Graft Substitutes, Viscosupplementation, Bone Allografts and Bone Growth Stimulators.
- Annualized market revenues (USD million), volume (units) and average selling price ($) data for each of the market categories. Data is provided from 2005 to 2012 and forecast to 2020.
- 2012 company shares and distribution shares data for each of the market categories.
- Global corporate-level profiles of key companies operating within the Russia Orthobiologics market.
- Key players covered include DePuy Companies, Sanofi, Medtronic, Inc., NuVasive, Inc., Biomet, Inc., Smith & Nephew Plc, Baxter International Inc., Wright Medical Group, Inc., Stryker Corporation and Alphatec Holdings, Inc.

Reasons to buy

- Develop business strategies by identifying the key market segments poised for strong growth in the future.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the market.
- Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize.
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 4
2 Introduction 5

2.1 What Is This Report About? 5
2.2 Orthobiologics Market Segmentation 5
2.3 Definitions of Markets Covered in the Report 6
3 Orthobiologics Market, Russia 7
3.1 Orthobiologics Market, Russia, Revenue ($m), 2005-2012 7
3.2 Orthobiologics Market, Russia, Revenue ($m), 2012-2020 9
3.2.1 Bone Graft Substitutes Market, Russia, Revenue ($m), by Segment, 2005-2012 11
3.2.2 Bone Graft Substitutes Market, Russia, Revenue ($m), by Segment, 2012-2020 13
3.3 Orthobiologics Market, Russia, Volume (Units), 2005-2012 15
3.4 Orthobiologics Market, Russia, Volume (Units), 2012-2020 17
3.4.1 Bone Graft Substitutes Market, Russia, Volume (Units), by Segment, 2005-2012 19
3.4.2 Bone Graft Substitutes Market, Russia, Volume (Units), by Segment, 2012-2020 21
3.5 Orthobiologics Market, Russia, Average Price ($), 2005-2020 23
3.6 Orthobiologics Market, Russia, Distribution Share by Revenue ($m), 2011-2012 25
3.7 Orthobiologics Market, Russia, Company Share by Revenue ($m), 2011-2012 26
4 Overview of Key Companies in Russia Orthobiologics Market 28
4.1 DePuy Companies 28
4.1.1 Company Overview 28
4.2 Biomet, Inc. 28
4.2.1 Company Overview 28
4.3 Medtronic, Inc. 28
4.3.1 Company Overview 28
4.4 Orthofix International N.V. 29

4.4.1 Company Overview 29
4.5 Baxter International Inc. 29
4.5.1 Company Overview 29
4.6 Smith & Nephew Plc 29
4.6.1 Company Overview 29
4.7 Stryker Corporation 30
4.7.1 Company Overview 30
4.8 Wright Medical Group, Inc. 30
4.8.1 Company Overview 30
4.9 Ferring International Center S.A. 31
4.9.1 Company Overview 31
5 Orthobiologics Market Pipeline Products 32
6 Financial Deals Landscape 34
6.1 Asset Transactions 34
6.1.1 Biomet Completes Acquisition Of Trauma Business Of Depuy Orthopaedics For US$280 Million 34
6.2 Partnerships 36
6.2.1 Artimplant Enters Into Co-Marketing Agreement With Tiller International Capital 36
6.2.2 aap Implantate Enters Into Licensing Agreement With Medical Technology Company For Injectable Bone Matrix 37
7 Appendix 38
7.1 Research Methodology 39
7.1.1 Coverage 39
7.1.2 Secondary Research 39
7.1.3 Primary Research 40
7.1.4 Market Modeling and Forecasting 41
7.1.5 Company Share Analysis 44

7.1.6 Distribution Share Analysis 45
7.2 Expert Panel 45
7.3 GlobalData Consulting 46
7.4 Contact Us 46
7.5 Disclaimer 46

List of Tables

Table 1: Orthobiologics Market, Russia, Revenue ($m), USD Constant, Historic, 2005-2012 8
Table 2: Orthobiologics Market, Russia, Revenue ($m), USD Constant, Forecast, 2012-2020 10
Table 3: Bone Graft Substitutes Market, Russia, Revenue ($m), USD Constant, Historic, 2005-2012 12
Table 4: Bone Graft Substitutes Market, Russia, Revenue ($m), USD Constant, Forecast, 2012-2020 14
Table 5: Orthobiologics Market, Russia, Volume (Units), Historic, 2005-2012 16
Table 6: Orthobiologics Market, Russia, Volume (Units), Forecast, 2012-2020 18
Table 7: Bone Graft Substitutes Market, Russia, Volume (Units), Historic, 2005-2012 20
Table 8: Bone Graft Substitutes Market, Russia, Volume (Units), Forecast, 2012-2020 22
Table 9: Orthobiologics Market, Russia, Average Price ($), Historic, 2005-2012 23
Table 10: Orthobiologics Market, Russia, Average Price ($), Forecast, 2012-2020 24
Table 11: Orthobiologics Market, Russia, Distribution Share by Revenue ($m), USD Constant, 2011-2012 25

Table 12: Orthobiologics Market, Russia, Company Share by Revenue ($m), USD Constant, 2011-2012 27
Table 13: Orthobiologics Market Pipeline Products 32
Table 14: Biomet Completes Acquisition Of Trauma Business Of Depuy Orthopaedics For US$280 Million 34
Table 15: Artimplant Enters Into Co-Marketing Agreement With Tiller International Capital 36
Table 16: aap Implantate Enters Into Licensing Agreement With Medical Technology Company For Injectable Bone Matrix 37
Table 17: Total Number of Primary Research Participants, Orthopedic Devices Market, by Country 41

List of Figures

Figure 1: Orthobiologics Market, Russia, Revenue ($m), USD Constant, Historic, 2005-2012 7
Figure 2: Orthobiologics Market, Russia, Revenue ($m), USD Constant, Forecast, 2012-2020 9
Figure 3: Bone Graft Substitutes Market, Russia, Revenue ($m), USD Constant, Historic, 2005-2012 11
Figure 4: Bone Graft Substitutes Market, Russia, Revenue ($m), USD Constant, Forecast, 2012-2020 13
Figure 5: Orthobiologics Market, Russia, Volume (Units), Historic, 2005-2012 15
Figure 6: Orthobiologics Market, Russia, Volume (Units), Forecast, 2012-2020 17
Figure 7: Bone Graft Substitutes Market, Russia, Volume (Units), Historic, 2005-2012 19
Figure 8: Bone Graft Substitutes Market, Russia, Volume (Units), Forecast, 2012-2020 21
Figure 9: Orthobiologics Market, Russia, Company Share (%) 2012 26
Figure 10: GlobalData Epidemiology-Based Forecasting Model 43
Figure 11: GlobalData Capital Equipment-Based Forecasting Model 44
Figure 12: Primary Interviews by Participant Type (%) 45